Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
- 11 March 2008
- journal article
- research article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 5 (5) , 248-249
- https://doi.org/10.1038/ncpcardio1153
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationCirculation, 2007
- ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac DeathJournal of the American College of Cardiology, 2006
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive SummaryJournal of the American College of Cardiology, 2006
- Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic PropertiesCirculation, 2004